Published in Ethn Dis on October 20, 2016
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem (1972) 95.79
Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA (2014) 36.94
Cancer-related inflammation. Nature (2008) 34.21
Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (1993) 25.54
STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer (2009) 15.45
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst (2006) 6.41
Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell (2012) 5.44
Diabetes and cancer. Endocr Relat Cancer (2009) 5.04
Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA (2003) 4.76
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat (2010) 4.58
Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol (2002) 4.55
Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol (2005) 4.04
Decline in skeletal muscle mitochondrial function with aging in humans. Proc Natl Acad Sci U S A (2005) 4.03
Adiponectin and breast cancer risk. J Clin Endocrinol Metab (2004) 2.72
Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest (2011) 2.62
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr Relat Cancer (2007) 2.45
Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res (2003) 2.35
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res (1999) 2.17
Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett (2005) 2.13
Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes. Diabetologia (2006) 2.07
Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol (2005) 2.01
Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer (2006) 2.00
Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol (2009) 1.98
Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res (2002) 1.90
Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG (2006) 1.66
Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group. J Am Diet Assoc (1999) 1.59
Exercise with calorie restriction improves insulin sensitivity and glycogen synthase activity in obese postmenopausal women with impaired glucose tolerance. Am J Physiol Endocrinol Metab (2011) 1.28
Reductions in plasma cytokine levels with weight loss improve insulin sensitivity in overweight and obese postmenopausal women. Diabetes Care (2004) 1.22
Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev (2013) 1.14
Weight gain with breast cancer adjuvant treatment. Cancer (1991) 1.11
Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J Cell Biochem (2012) 1.10
Effects of a weight loss intervention on body mass, fitness, and inflammatory biomarkers in overweight or obese breast cancer survivors. Int J Behav Med (2011) 1.02
Estradiol increases IL-8 secretion of normal human breast tissue and breast cancer in vivo. J Immunol (2009) 1.01
Aerobic exercise and weight loss reduce vascular markers of inflammation and improve insulin sensitivity in obese women. J Am Geriatr Soc (2014) 0.99
A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer. Int J Oncol (2012) 0.96
Insights into the roles of the inflammatory mediators IL-1, IL-18 and PGE2 in obesity and insulin resistance. Swiss Med Wkly (2008) 0.95
Weight change patterns among breast cancer survivors: results from the Shanghai breast cancer survival study. Cancer Causes Control (2009) 0.95
Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer. Cancer (2008) 0.94
Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells. Stem Cell Res Ther (2012) 0.92
The influence of inflammatory cytokines on estrogen production and cell proliferation in human breast cancer cells. Endocr J (2002) 0.92
Weight gain following breast cancer diagnosis: Implication and proposed mechanisms. World J Clin Oncol (2014) 0.91
Relation between insulin resistance and serum concentrations of IL-6 and TNF-alpha in overweight or obese women with early stage breast cancer. Cytokine (2005) 0.87
Associations of adipokines & insulin resistance with sex steroids in patients with breast cancer. Indian J Med Res (2012) 0.82
Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2009) 0.76